NK

NantKwest
NASDAQ

实时行情|Nasdaq Last Sale

1.140
+0.020
+1.79%
已收盘, 16:00 11/11 EST
开盘
1.120
昨收
1.120
最高
1.160
最低
1.100
成交量
5.40万
成交额
--
52周最高
2.910
52周最低
0.9300
市值
1.12亿
市盈率(TTM)
-1.2573
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

落后大盘

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NK 新闻

  • 智能眼镜成新风口?盘点美国七家制造商的AR设备
  • 新浪美股.2小时前
  • 收盘:美股涨跌不一 波音推动道指创新高
  • 新浪美股.2小时前
  • 美国原油期货价格周一收跌0.7%
  • 新浪美股.3小时前
  • 尾盘:美股涨跌不一 波音推动道指转涨
  • 新浪美股.3小时前

更多

所属板块

生物技术和医学研究
-0.51%
制药与医学研究
-0.43%

热门股票

名称
价格
涨跌幅

NK 简况

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or infected cell by direct killing by binding to stress ligands expressed by the diseased cell with the release of toxic granules directly into the tumor cell; antibody mediated killing by binding to antibodies administered in combination and enhancing the cancer killing effect of the administered antibody, enabling targeted cell killing through antibody dependent cellular cytotoxicity (ADCC), and target activated killing by binding to known or newly discovered tumor-specific antigens expressed on the surface of tumor cells and inducing cell death by the release of toxic granules directly into the tumor cell and by the release of cytokines and chemokines.
展开

Webull提供Nantkwest Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。